Iván Hernández Dalas: Surgerii Robotics obtains Series D funding to take single-port system global

The SHURUI SP single-port endsocopic robotic surgical system from Surgerii.

The SHURUI SP single-port endsocopic surgical system has CE approval. Source Surgerii Robotics

Surgerii Robotics Co. this month closed $100 million in Series D financing. The Beijing-based company said it will use the funding to market its SHURUI single-port surgical robot both domestically and internationally, as well as to accelerate the production of its next-generation products.

Single-port surgery is a minimally invasive approach involving endoscope and surgical instruments through a single incision. Surgerii said its SHURUI robot uses snake-like instruments and teleoperation technology to assists clinicians in achieving precise operations.

Surgerii develops, produces, and commercializes laparoscopic surgical robotic systems and accessories. In September 2025, it obtained CE approval in Europe for SHURUI. The company claimed that it was the second such approval after Intuitive Surgical received a CE mark for its da Vinci SP system in 2024.

SITE AD for the 2026 Robotics Summit save the date.

Surgerii touts surgical innovations

The SHURUI single-port endoscopic surgical system, or SR-ENS-600, is “the world’s first commercially available single-port surgical robot with snake-like instruments,” claimed Surgerii Robotics. The company noted that it has been building its intellectual property (IP) portfolio.

The core technology of the SHURUI SP robot is based on the “Dual Continuum Mechanism” design developed by Prof. Kai Xu of Shanghai Jiao Tong University. Surgerii said the innovation enabled the development of its flexible instruments, which can perform highly complex and precise procedures through a single 1.8 cm (0.7 in.) incision.

During its financing round, investors systematically reviewed Sugerii’s IP, mapping the global technological and patent landscape. This included a detailed comparative analysis between SHURUI SP and more than 3,000 valid, granted patents held by leading endoscopic surgical robot companies across Europe and the U.S.

Surgerii said the analysis found that, despite the highly dense patent landscape, its robot “has achieved disruptive innovation and breakthroughs in key technologies.” The company asserted that its approach is significantly distinguished from existing surgical patents, providing a solid technological and legal foundation to operate and commercialize SHURUI in international markets.

A mimial incision through the navel provides access for a steerable robot, says Surgerii.

A mimial incision through the navel provides access for a steerable robot. Source: Surgerii Robotics

SHURUI approved for adult, pediatric patients

The SR-ENS-600 can be applied in urology and gynecology laparoscopic surgeries for benign and malignant diseases, said Surgerii Robotics. Its application in general surgery and thoracic surgery is under review.

SHURUI SP obtained the marketing approval from China’s National Medical Products Administration (NMPA) in June 2023. Surgerii said it was first single-port endoscopic surgical robot to gain such approval in China.

In August 2025, the robot received CE certification, enabling its use across urology, gynecology, general surgery, and thoracic surgery for both adult and pediatric patients. Surgerii claimed it is the only CE-certified single-port surgical robot approved for pediatric use and the first Chinese surgical robot to be certified for the use in patients of all age group.

To date, the company has established clinical cooperation with over 70 Grade A tertiary hospitals in China, performed more than 3,000 surgeries, been involved in nearly 50 procedures worldwide, and developed over 80 surgical techniques that fill gaps in clinical practice across Asia or China. These procedures range from pancreaticoduodenectomy for pancreatic cancer to surgeries on pediatric patients as young as 7 days old.

Surgerii said it has demonstrated that its technology can reduce surgical trauma while covering an even broader patient population than multi-port surgical robots. SHURUI does not yet have U.S. Food and Drug Administration approval.

Surgerii demonstrates its flexible and patented instruments handling an egg.

A demonstration of SHURUI’s flexible and patented instruments handling an egg. Source: Surgerii Robotics

Investment to boost European adoption

Loyal Valley Capital, a private equity firm focusing on healthcare and technology innovations, led Surgerii Robotics’ Series round.

Other participants included Shanghai Healthcare Capital, a strategic investor in healthcare segment leaders; V Star Capital and DNV Capital, both specializing in healthcare innovations; and Hefei Industrial Investment, an investor with extensive experience and industrial resources in hard technology and strategic emerging industries.

Surgerii noted that this investment came as it is deepening its domestic market penetration and accelerating international commercialization.

“Leveraging the strong support from this new round financing, the company will further the clinical adoption, develop advanced energy instruments, thereby deepening the therapeutic value of single-port robots in more and complex cases, as well as creating a disruptive systematic solution centered on cutting-edge technology to benefit a wider range of patients,” it stated.

In 2025, Surgerii established the European Clinical Excellence Center in collaboration with IRCAD, a leading institution for minimally invasive surgical training. The company added that it has set its strategic focus on the high-end European market.

The post Surgerii Robotics obtains Series D funding to take single-port system global appeared first on The Robot Report.



View Source

Popular posts from this blog

Iván Hernández Dalas: 4 Show Floor Takeaways from CES 2019: Robots and Drones, Oh My!

Image
We’ve had some time to recuperate from the madness of CES, in which more than 150,000 attendees and thousands of exhibitors displayed their latest gadgets, gizmos and yes, even robots, on the CES show floor. Last week’s reporter’s notebook focused on the collection of startups around the Eureka Park area of CES, but several of the same trends were evident on the main South Hall 2 area of the Las Vegas Convention Center, where drones, robotics, AR/VR, and gaming took center stage. While most of our time was spent at CES hosting the Service Robots Arrive in Daily Life event, we did have some time during the week to visit the show floor and record observations. Here’s what we saw on the show floor, as well as some of our own individual meetings: 1. Underwater drones make a big splash On the main floor, there was no busier aerial drone booth than the DJI booth, but that is expected given the company’s dominance in the space. But once you got past that, you noticed a lot more drone co...
Read more

Iván Hernández Dalas: How automation and farm robots are transforming agriculture

Image
Source: EOS Data Analytics Agriculture is becoming the most high-tech industry today. All the top-notch technologies are finding a place in the way we produce, harvest, and distribute our crops. And in all cases, farm automation and robots are not an affordable luxury, but a necessary minimum due to tackling the rising global food demand. Agricultural robots can mitigate labor shortages by automating tasks like planting, harvesting, and weeding, while also supporting sustainable practices. Combined with satellite imagery tools for data-driven farming, these innovations can make precision agriculture more efficient, resilient, and environmentally responsible. According to the United Nations report , by 2050, the world will need 70% more food to feed nearly 9.7 billion people. Considering this demand, farm robots and remote sensing are the cornerstone of the proper work of the supply chain. Smart machines arise for the farm Farm robots are no longer experimental concepts — they ...
Read more

Iván Hernández Dalas: Tacta Systems raises $75M to give robots a ‘smart nervous system’

Image
Tacta Systems said its technology enables robots to perform delicate, variable, human-like tasks with flexibility, efficiency, and autonomy. | Source: Adobe Stock Tacta Systems Inc., which is developing dexterous intelligence to give robots tactile skills and spatial awareness, last week raised $75 million. The Palo Alto, Calif.-based startup said it will use the funding to accelerate the development of systems capable of performing complex, human-like tasks. “Enabling machines to solve complex, physical world problems is the next frontier in robotics technology,” stated Andreas Bibl, co-founder and CEO of Tacta Systems. “AI models have become incredibly sophisticated in working with text and video, but much of the physical world remains incomprehensible to them,” he said. “We’re incredibly excited about the disruptive technology that we’re developing, which will ultimately help humanity automate much of the drudgery of factory work and grueling physical labor.” Tacta said its br...
Read more